Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

HYDROXYCHLOROQUINE 100 MG TAB

Hydroxychloroquine Sulfate
$0.1706per EA
High Outlier

Strength

100 mg/1

Manufacturer

Accord Healthcare Inc.

NDC

16729056101

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

10/23/2024

Active Ingredients

HYDROXYCHLOROQUINE SULFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA213342

On Market Since

9/28/2021

Pharmacological Classes

Antimalarial
Antirheumatic Agent

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

-6.0%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

HYDROXYCHLOROQUINE 200 MG TAB
Generic
00904704606•Major Pharmaceuticals
$0.1622
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
00904704661•Major Pharmaceuticals
$0.1622
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
16714011001•NorthStar Rx LLC
$0.1622
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
16714011002•NorthStar Rx LLC
$0.1622
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
43598072101•Dr. Reddy's Laboratories Inc.
$0.1622
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
43598072105•Dr. Reddy's Laboratories Inc.
$0.1622
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
50268041215•AvPAK
$0.1622
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
59651088901•Aurobindo Pharma Limited
$0.1622
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
59651088905•Aurobindo Pharma Limited
$0.1622
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
68382009601•Zydus Pharmaceuticals (USA) Inc.
$0.1622
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy